
Join to View Full Profile
- 5115 Centre Ave# UpmcPittsburgh, PA 15232 
- Phone+1 412-623-7955 
Dr. Drappatz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuro-Oncology, 2004 - 2005 Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuro-Oncology, 2004 - 2005
 Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2001 - 2004 Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2001 - 2004
 Boston University Medical CenterInternship, Internal Medicine, 2000 - 2001 Boston University Medical CenterInternship, Internal Medicine, 2000 - 2001
 Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1999 Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1999
Certifications & Licensure
 PA State Medical License 2011 - 2026 PA State Medical License 2011 - 2026
 MA State Medical License 2004 - 2012 MA State Medical License 2004 - 2012
 American Board of Psychiatry and Neurology Neurology American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Member Best Doctors
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Corticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.Maged T Ghoche, Kenji Miki, Skyler Oken, Namya Manoj, Neslihan Nisa Gecici
 Neurosurgery. 2025-10-02
- 1 citationsClinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.Matthew K Nguyen, Mark Jelinek, Arjun Singh, Brian Isett, Erica S Myers
 Medrxiv. 2025-07-21
- 5 citationsGlucarpidase for treatment of high-dose methotrexate toxicity.Shruti Gupta, Sarah A Kaunfer, Kevin L Chen, Julie-Alexia Dias, Anitha Vijayan
 Blood. 2025-04-24
Other
- Seizures in patients with primary and metastatic brain tumorsDrappatz J, Avila EK, Wen PY
 http://www.uptodate.com/contents/seizures-in-patients-with-primary-and-metastatic-brain-tumors
 UpToDate, Wolters Kluwer Health - 2013-04-03
- Management of vasogenic edema in patients with primary and metastatic brain tumorsDrappatz J, Wen PY
 http://www.uptodate.com/contents/management-of-vasogenic-edema-in-patients-with-primary-and-metastat
 UpToDate, Wolters Kluwer Health - 2013-02-13
- Systemic therapy for brain metastasesDrappatz J, Wen PY
 http://www.uptodate.com/contents/systemic-therapy-for-brain-metastases
 UpToDate, Wolters Kluwer Health - 2012-12-07
Press Mentions
 Classifying Childhood Brain Cancers by Immune Response May Improve Diagnostics and TreatmentsMarch 19th, 2025 Classifying Childhood Brain Cancers by Immune Response May Improve Diagnostics and TreatmentsMarch 19th, 2025
 Benefits of WBRT for Brain MetastasesAugust 2nd, 2019 Benefits of WBRT for Brain MetastasesAugust 2nd, 2019
 New Molecule Found to Cross the Blood‐Brain Barrier: Reporte... : Neurology TodayFebruary 28th, 2017 New Molecule Found to Cross the Blood‐Brain Barrier: Reporte... : Neurology TodayFebruary 28th, 2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









